Actively Recruiting
Effectiveness of Thumbtack Needle Therapy for Chronic Insomnia in Perimenopausal and Menopausal Women A Multicenter Randomized Controlled Trial
Led by Huazhong University of Science and Technology · Updated on 2026-10-27
198
Participants Needed
8
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effects of thumbtack needle therapy on sleep in women with chronic insomnia during perimenopause and menopause. This multicenter, randomized, controlled, and blinded trial involves 198 women aged 40 to 65 years. The study aims to compare the effects of thumbtack needle treatment with placebo thumbtack needle treatment over a 4-week period. Participants are randomly assigned to one of two groups the treatment group receives thumbtack needle therapy at 11 specific acupoints, and the control group receives placebo thumbtack needle therapy at the same acupoints with comforting acupressure. Treatments are given twice a week, with needles retained for 3 days before removal and skin disinfection. Patients rest one day between treatments, completing a total 4-week course. During the study, participants will be assessed using multiple sleep-related scales and indexes such as the Insomnia Severity Index, Pittsburgh Sleep Quality Index, and Epworth Sleepiness Scale, among others. Researchers will monitor sleep efficiency, wake times, hormone levels, and insomnia remission rates. Safety and treatment response will be evaluated throughout the 4 weeks, with the primary outcome measured by the Insomnia Severity Index at 4 weeks.
CONDITIONS
Brief Title
Clinical Efficacy of Thumbtack Needle for Chronic Insomnia in Perimenopausal and Menopausal Women
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here